Association of serum fetuin-A with carotid arterial stiffness

Katsuhito Mori1, Masanori Emoto, Takahiro Araki

  • 1Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan. ktmori@med.osaka-cu.ac.jp

Clinical Endocrinology
|January 17, 2007
PubMed

Insights

Serum fetuin-A levels are linked to arterial stiffness in healthy individuals. This finding suggests fetuin-A may play a role in atherosclerosis development beyond its known function in vascular calcification.

Area of Science:

  • Biochemistry
  • Cardiovascular Medicine
  • Nephrology

Background:

  • Fetuin-A is a glycoprotein known to inhibit ectopic calcification.
  • Vascular calcification in chronic kidney disease (CKD) patients predicts cardiovascular death.
  • Low fetuin-A levels correlate with mortality in uremic patients, potentially via vascular calcification regulation.

Purpose of the Study:

  • To investigate the association between serum fetuin-A levels and arterial stiffness.
  • To explore the role of fetuin-A in atherosclerosis in healthy subjects.

Main Methods:

  • Study included 141 healthy subjects.
  • Serum fetuin-A levels were measured.
  • Carotid arterial stiffness (stiffness parameter beta) was assessed using ultrasound and phase-locked echo-tracking.

Main Results:

  • Serum fetuin-A levels showed a significant correlation with stiffness parameter beta (r = 0.200, P = 0.018).
  • Fetuin-A independently contributed to stiffness parameter beta, alongside age (beta = 0.166, P = 0.033).
  • Multiple regression analysis indicated R(2) = 0.310, P < 0.0001.

Conclusions:

  • Serum fetuin-A levels are associated with carotid arterial stiffness in healthy individuals.
  • This association is independent of known atherogenic factors.
Abstract